Much of the morbidity and mortality in patients with cystic fibrosis (CF) is secondary to pulmonary infections with Pseudomonas aeruginosa and, more recently, with Pseudomonas cepacia. Prevention of colonization and subsequent infection would be a useful therapeutic strategy. The pili (fimbriae) of P. aeruginosa are a potential vaccine antigen, as they have been implicated in binding to respiratory epithelium and appear to have limited antigenic diversity. Monoclonal antibodies (MAbs) raised to P. aeruginosa pilin demonstrated significant cross-reactivity, as four of five P. aeruginosa strains with known pilin sequences and 10 of 15 P. aeruginosa clinical isolates hybridized by immunoblot with at least one of the three MAbs tested. The P. cepacia strains demonstrated minimal cross-reactivity with these MAbs, as only 2 of 16 strains hybridized immunologically. The three MAbs decreased the adherence of 35S-labeled P. aeruginosa PA1244 to bovine tracheal cells by 56, 45, and 31%. One of these MAbs decreased the adherence of strains P. aeruginosa PAO1 and P. cepacia 249 to CF epithelial cells by 46 and 25%, respectively. While antibodies to Pseudomonas pili must be shown to be protective in patients with CF, these studies give support for a multivalent vaccine strategy using P. aeruginosa pilin as the immunogen.
Pseudomonas aeruginosa, and more recently Pseuldomonas cepacia, are the pulmonary pathogens that cause the major morbidity and mortality in patients with cystic fibrosis (8, 23) . Prevention of initial colonization of the respiratory epithelium by P. aeruginosa could be a potentially effective therapeutic strategy. In theory, this could be accomplished by immunizing young infants with an antigen capable of generating a protective antibody response. The pili (fimbriae) of P. aeruginosa have several characteristics that make them a potential antigen for a vaccine (28) . Pili seem to be involved in colonization of epithelial cells (35) . Although unequivocal proof is still lacking, several investigators have documented that purified pilin competitively inhibited the adherence of piliated strains to a variety of respiratory epithelial cells, including human buccal cells, acid-injured mouse tracheal cells, and human tracheal cells (6, 24, 35) . Unlike Neisseria gonorrheae, which has multiple pilin loci in a single strain (26) , P. aeruginosa has a single copy of the pilin structural gene (20) . In vivo, the clinical isolates of a patient with cystic fibrosis (CF) maintained the same pilin sequence without rearrangement for several years, although pilus expression varied (21) . In addition, P. aeriuginosa pilins have a limited number of antigenic variations, since there appear to be 10 serogroups (19) .
Several pilin genes from clinical isolates of P. aeruginosa have been sequenced, and like those of N. gonorrheae, P. aeruginosa pilins are of the NMePhe class (19) . They possess homologous hydrophobic amino acid termini that are likely to be involved in subunit-subunit interaction and are immunorecessive. The central region is variable, superficial, and immunodominant. The carboxy termini are semiconserved and have a disulfide bridge which has been implicated in binding to epithelial cells (6, 16 (5) . With the exception of a single amino acid, its pilin sequence is identical to that of the pilin of strain P1 (sequenced independently by Pasloske et al. [22] ). PAO1 has been extensively Micro Scan, Mahwah, N.J.) and confirmed by the API 20E System (Sherwood Medical, Plainview, N.Y.), DNase production (3), and growth on P. cepacia media (Scott, Fiskeville, R.I.). All strains were grown in M9 medium at 37°C with aeration unless otherwise specified (18) .
Pilin preparation. Purified pilin for MAb production from P. aeruginosa PA1244, PT2A, and 686 was the kind gift of C. Brinton. Purity was confirmed by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis demonstrating a single protein band of 18,000 molecular weight (14) .
MAb preparation. MAbs to purified P. aeruginosa pilins were prepared by the method of Kohler and Milstein (13) Widdecombe et al. (33) , with the following modifications. All chemicals and reagents were obtained from Sigma Chemical Co., St. Louis, Mo., unless otherwise specified. The tissue was finely minced and suspended in HEPES (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid)-buffered Ringer solution (pH 7.4) and 10 mM glucose with the following: bovine serum albumin (1 mg/ml), collagenase (200 ,ug/ml), dithiothreitol (150 ,ug/ml), hyaluronidase (50 ,ug/ml), DNase (100 jig/ml), elastase (25 ,u1/liter), and soybean trypsin inhibitor (100 p.g/ml) for 30 min in a trypsinizing flask. The solid matter was pelleted and suspended in the same cell isolation buffer (pH 7.4) without enzymes and with 20 mM Ca2"-Mg2"-free EDTA for 10 min.
The solid material was then suspended in the cell isolation buffer containing enzymes.
The epithelial cells were harvested from the supernatant and suspended in Dulbecco modified Eagle medium (250 ml; 4.5 mg of glucose per ml) and Ham F12 (250 ml; Mediatech, Herndon, Va.) containing insulin (5 pg/ml), transferrin (5 pg/ml), selenous acid (5 ng/ml), hydrocortisone (12.5 p.g/ml), epidermal growth factor (15 ng/ml), ethanolamine (5 x 10-4 M), phosphoethanolamine (5 x 10 M), glutamine (2 mM), penicillin (100 U/ml), streptomycin (100 p.g/ml), amphotericin B (4 ,ug/ml), gentamicin (50 pg/ml), and bovine pituitary extract (Pelfreez, Rogers, Ark.) prepared by the method of Tsao (30) . The medium for the nasal polyp was supplemented with 10% fetal calf serum (GIBCO Laboratories, Grand Island, N.Y.), thyroid hormone (2 x 10-10 M), and cholera toxin (10 ng/ml) (36) . The epithelial cells were plated at a density of 106 cells per ml in 24-well tissue culture plates (Nunc, Roskilde, Denmark) coated with human placental collagen type VI. The monolayers reached confluence in 5 to 7 days and could be passaged up to five times without losing their epithelial morphology or changing their binding characteristics.
Characterization of monolayers. The epithelial cell monolayers were characterized by phase-contrast light microscopy and electron microscopy to assess uniformity, confluence, and morphologic features. Consistent cell number per well was determined by protein concentration by the method of Bradford (2) and confirmed by cell count after trypsinization of the monolayers. Immunofluorescent staining was performed on monolayers grown on glass cover slips. The cells were briefly dipped in 100% methanol and then in acetone and then were stained with anti-keratin IgG (epithelial cytoskeletal marker; Dupont, NEN Research Products, Wilmington, Del.). or anti-vimentin IgG (fibroblast cytoskeletal marker) to confirm epithelial cell type (15) . To determine that the monolayers had the electrophysiologic properties characteristic of epithelial cells, the monolayers were grown on porous polycarbonate filters and mounted in Ussing chambers to measure resistance and potential difference (33) .
Adherence assay. Adherence assays were done to quantify the binding of Pseudomonas cells to the confluent monolayers as follows. Pseudomonas cells were grown in M9 broth to a density of approximately 5 x 108 CFU/ml. Four microliters of 35S-labeled amino acids (1,100 to 1,200 Ci/mM) (Dupont, NEN Research Products) were added to the bacteria for 10 min. The unincorporated label was removed by centrifuging the Pseudomonas cells at 14,000 rpm for 5 min at 25°C in a microfuge (Brinkmann Instruments, Inc., Westbury, N.Y.) and washing with 1 ml of 10 mM NaCl. The labeled Pseudomonas cells were suspended in epithelial cell medium with cycloserine (100 p.g/ml) to inhibit bacterial cell division during the adherence assay. Labeled bacteria (5 x 107 CFU/ml [100 p.l]) were suspended in 0.4 ml of tissue culture medium and added to the respiratory epithelial cells for 2 h at 25°C on a shaker table. The monolayers were rinsed three times with phosphate-buffered saline for 20, 10, and 10 s to remove the nonadherent Pseiudomonas cells. The monolayer with adherent Pseudomonas cells was solubilized in 2% SDS and placed in 4 ml of Aquasol (Dupont, NEN Research Products), and scintillations were counted for 2 min (Isocap/300; Searle).
Equal portions of the initial cell suspension were plated, and scintillations were counted to calculate the number of Pseudomonas cells associated with the counts per minute. All experiments were done in triplicate. Serial dilutions of the labeled bacteria were made, and concentrations from 105 to 10' CFU/ml were added to the monolayer to saturate the receptors and to establish the binding kinetics of the assay. The binding of identical portions of labeled bacteria to the VOL. 57, 1989 on November 6, 2017 by guest http://iai.asm.org/ Downloaded from The extent of the conservation of pilin epitopes was further studied by using Western immunoblot techniques. MAb 6.45 recognized common epitopes in strains PA1244 and PAK (Fig. 2) . Strains PA103 (data not shown), P1, and PAO1 did not cross-react with this MAb. MAb 297.7 recognized common epitopes on the pilin of five clinical isolates (Fig. 3) . Overall, 9 of 15 isms was the same at the start and the conclusion of the assay.
Effects of MAbs on adherence. The effects of MAbs 6.45 and 297.7 on the binding of PA1244 to bovine tracheal cells are shown in Fig. 4 . These MAbs decreased adherence of PA1244 by 45 and 31%, respectively, compared with the control MAb, which had no significant effect on adherence. Serial dilutions of MAb 6.45 had progressively less of an effect on the adherence of PA1244, as both 1:100 and 1:1,000 dilutions of this MAb inhibited adherence by 31%. MAb 6.45 also decreased the adherence of the strains PAO1, PAK, and PA103, but it had no effect on the adherence of strain P1 (Fig. 5) . The effect of antipilin MAbs 6.45 and 6.11 on the adherence of strains PA01 and P. cepacia 249 to CF nasal polyp cells is shown in Fig. 6 . MAb 6.45 decreased the adherence of both PA01 and 249 by 33 and 25%, respectively. MAb 6.11 decreased the adherence of PAO1 by 56% but had no significant effect on the adherence of 249. Thus, each of the three MAbs blocked the adherence of P. aeruginosa strains to both bovine trachea and CF nasal polyp epithelial cell monolayers.
DISCUSSION
The studies presented here demonstrate that the pili of different P. aeruginosa strains share important cross-reactivity. In addition to finding that a MAb raised to a specific pilin type could identify a similar epitope on strains known to have different pilin sequences, the cross-reactive MAb was also able to function biologically and could inhibit the adherence of these heterogenous P. aeruginosa strains. This has obvious therapeutic implications. While a single MAb did not cross-react with all the strains used, a limited number of pilin sequences would make production of a multivalent vaccine possible.
These results are in contrast to previous studies which have demonstrated that antipilin antisera or FAb fragments could inhibit the binding of homologous P. aeruginosa strains to acid-injured human trachea or buccal cells but could not inhibit the binding of heterologous strains (6, 24) . Several methodological variables can account for this apparent discrepancy. The three MAbs used in our studies were selected from 15 different cell fusions from animals boosted with heterologous pilins, which increased the likelihood that cross-reactive MAbs would be identified. High titers of antibody were used in the studies presented here; we used a 1:10 dilution, while previous investigators used 1:100 and 1:2,048 dilutions (6, 24 (7, 17) , and 10 have been described for P. aeruiiginosa (19) . The pilins of both species share extensive sequence homology, physical properties, and cellular distribution (7) . By using a multivalent vaccine composed of eight pilin serogroups, a successful vaccine strategy has been developed to prevent ovine foot rot caused by B. nodosius (17) . Experience with these two other species can serve as models for the development of a vaccine to prevent P. aeruginosa colonization of the respiratory epithelium of young infants. Early diagnosis and intervention in infants with CF is becoming increasingly practical (27, 34) . Theoretically, prevention of colonization and subsequent infection would decrease the antigenic stimulation and immune complex damage caused by prolonged infection with P.
aer-uginosa (10, 32) . Studies will be needed to document that antipilin antibodies in CF patients are protective and prevent the establishment of P. aeruiginosa infection.
